reported its Q1 2026 financial results on May 5, 2026, delivering a beat on both top and bottom lines as the company continues its transition away from peak pandemic-era revenues. Operational revenue from “launched and acquired products” surged 22%, driven by strong performance in the oncology and specialty care portfolios.
Q1 2026 Earnings Summary
Adjusted EPS: $0.75 (Beat consensus estimate of $0.72 by $0.03).
Total Revenue: $14.45 billion (Beat estimate of ~$13.84 billion; up 5% year-over-year).
Honeywell International Inc. – Common strategic separation of the Aerospace division is finalized for 29 June 2026. Additionally, its quantum computing subsidiary, Quantinuum, has filed for an IPO (ticker: QNT).
Zscaler, Inc. – Common Earnings Announcement Coming Up. The company is scheduled to release Q3 FY2026 results on Tuesday, 26 May 2026, after market close. Analysts expect EPS of ~$1.00.
Sophisticated Investor?
We have special opportunities available for Sophisticated Investors. If you're interested, and qualify, please provide your details below.